Treatment of hepatocellular carcinoma with CIK cell therapy combined with mini-invasive TACE |
| |
| Authors: | ZHAO Jian-fu XU Meng |
| |
| Institution: | Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China |
| |
| Abstract: | Transcatheter arterial chemoembolization (TACE) has become an important way to treat hepatocellular carcinoma (HCC). TACE can kill HCC cells directly. Cytokine-induced killer (CIK) cell therapy improves immunity. CIK sequential therapy combined with TACE improves treatment safety, efficacy, the quality of life and long-term outcome for the HCC patients. This review summarizes the status and latest progress of CIK cell therapy combined with TACE in the treatment of HCC. |
| |
| Keywords: | Transcatheter arterial chemoembolization Mini-invasive treatment Cytokine-induced killer cells Hepatocellular carcinoma |
|
| 点击此处可从《园艺学报》浏览原始摘要信息 |
| 点击此处可从《园艺学报》下载免费的PDF全文 |
|
